Journal for ImmunoTherapy of Cancer (Jan 2022)
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
- Dirk Schadendorf,
- Lucie Heinzerling,
- Jessica C Hassel,
- Lisa Zimmer,
- Ralf Gutzmer,
- Lisa Villabona,
- Selma Ugurel,
- Thomas Eigentler,
- Peter Mohr,
- Thilo Gambichler,
- Patrick Terheyden,
- Sebastian Haferkamp,
- Claudia Pfoehler,
- Carmen Loquai,
- Jürgen Christian Becker,
- Ulrike Leiter,
- Hans-Ulrich Schildhaus,
- Ivelina Spassova,
- Linda Kubat,
- Annalena Mohr,
- Hannah Björn Andtback,
- Jochen S Utikal,
- Kai Horny,
- Daniel Habermann,
- Daniel Hoffmann
Affiliations
- Dirk Schadendorf
- Department of Dermatology, University Hospital of Essen, Essen, Germany
- Lucie Heinzerling
- Department of Dermatology-Oncology, University Hospital München, München, Germany
- Jessica C Hassel
- Department of Dermatology, University Hospital of Heidelberg, Heidelberg, Germany
- Lisa Zimmer
- Department of Dermatology, University Hospital of Essen, Essen, Germany
- Ralf Gutzmer
- Department of Dermatology, Skin Cancer Center Minden, Minden, Germany
- Lisa Villabona
- Department of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden
- Selma Ugurel
- Department of Dermatology, University Hospital of Essen, Essen, Germany
- Thomas Eigentler
- Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany
- Peter Mohr
- Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany
- Thilo Gambichler
- Department of Dermatology, Ruhr University Bochum, Bochum, Germany
- Patrick Terheyden
- Department of Dermatology, University Hospital of Lübeck, Lübeck, Germany
- Sebastian Haferkamp
- Department of Dermatology, University Hospital Regensburg, Regensburg, Germany
- Claudia Pfoehler
- Department of Dermatology, Saarland University Medical Center, Homburg, Germany
- Carmen Loquai
- Department of Dermatology, University Medical Center Mainz, Mainz, Germany
- Jürgen Christian Becker
- Translational Skin Cancer Research, Deutsches Konsortium für Translationale Krebsforschung, Essen, Germany
- Ulrike Leiter
- Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany
- Hans-Ulrich Schildhaus
- Department of Pathology, University Hospital Essen, Essen, Germany
- Ivelina Spassova
- Translational Skin Cancer Research, Deutsches Konsortium für Translationale Krebsforschung, Essen, Germany
- Linda Kubat
- Translational Skin Cancer Research, Deutsches Konsortium für Translationale Krebsforschung, Essen, Germany
- Annalena Mohr
- Department of Dermatology, University Hospital of Lübeck, Lübeck, Germany
- Hannah Björn Andtback
- Department of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden
- Jochen S Utikal
- Deutsches Krebsforschungszentrum, Heidelberg, Germany
- Kai Horny
- Translational Skin Cancer Research, Deutsches Konsortium für Translationale Krebsforschung, Essen, Germany
- Daniel Habermann
- Bioinformatics and Computational Biophysics, University of Duisburg-Essen, Duisburg, Germany
- Daniel Hoffmann
- Bioinformatics and Computational Biophysics, University of Duisburg-Essen, Duisburg, Germany
- DOI
- https://doi.org/10.1136/jitc-2021-003198
- Journal volume & issue
-
Vol. 10,
no. 1
Abstract
No abstracts available.